nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—CYP1A1—chronic obstructive pulmonary disease	0.185	0.509	CbGaD
Amiodarone—CYP1A2—chronic obstructive pulmonary disease	0.179	0.491	CbGaD
Amiodarone—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.0645	0.135	CbGbCtD
Amiodarone—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0489	0.102	CbGbCtD
Amiodarone—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0489	0.102	CbGbCtD
Amiodarone—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0396	0.0827	CbGbCtD
Amiodarone—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0396	0.0827	CbGbCtD
Amiodarone—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.03	0.0627	CbGbCtD
Amiodarone—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0176	0.0368	CbGbCtD
Amiodarone—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0164	0.0342	CbGbCtD
Amiodarone—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0164	0.0342	CbGbCtD
Amiodarone—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0148	0.0309	CbGbCtD
Amiodarone—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0136	0.0285	CbGbCtD
Amiodarone—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0136	0.0285	CbGbCtD
Amiodarone—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0128	0.0269	CbGbCtD
Amiodarone—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0124	0.026	CbGbCtD
Amiodarone—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0124	0.026	CbGbCtD
Amiodarone—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0111	0.0232	CbGbCtD
Amiodarone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0104	0.0218	CbGbCtD
Amiodarone—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0103	0.0216	CbGbCtD
Amiodarone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00705	0.0147	CbGbCtD
Amiodarone—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.00687	0.0144	CbGbCtD
Amiodarone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00673	0.0141	CbGbCtD
Amiodarone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00599	0.0125	CbGbCtD
Amiodarone—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00587	0.0123	CbGbCtD
Amiodarone—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00554	0.0116	CbGbCtD
Amiodarone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00352	0.00736	CbGbCtD
Amiodarone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00332	0.00695	CbGbCtD
Amiodarone—CACNA2D2—respiratory system—chronic obstructive pulmonary disease	0.000443	0.109	CbGeAlD
Amiodarone—THRA—connective tissue—chronic obstructive pulmonary disease	0.000394	0.0971	CbGeAlD
Amiodarone—CACNA1H—smooth muscle tissue—chronic obstructive pulmonary disease	0.00029	0.0713	CbGeAlD
Amiodarone—THRB—lung—chronic obstructive pulmonary disease	0.000238	0.0586	CbGeAlD
Amiodarone—THRA—lung—chronic obstructive pulmonary disease	0.000238	0.0586	CbGeAlD
Amiodarone—CACNA2D2—lung—chronic obstructive pulmonary disease	0.000235	0.058	CbGeAlD
Amiodarone—ADRB1—connective tissue—chronic obstructive pulmonary disease	0.000188	0.0463	CbGeAlD
Amiodarone—ADRB1—bronchus—chronic obstructive pulmonary disease	0.000176	0.0433	CbGeAlD
Amiodarone—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00176	CcSEcCtD
Amiodarone—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000174	0.00175	CcSEcCtD
Amiodarone—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00175	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000173	0.00174	CcSEcCtD
Amiodarone—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.00174	CcSEcCtD
Amiodarone—Cough—Formoterol—chronic obstructive pulmonary disease	0.000173	0.00174	CcSEcCtD
Amiodarone—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.00173	CcSEcCtD
Amiodarone—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000172	0.00172	CcSEcCtD
Amiodarone—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.00172	CcSEcCtD
Amiodarone—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000171	0.00171	CcSEcCtD
Amiodarone—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.00017	0.00171	CcSEcCtD
Amiodarone—Cough—Montelukast—chronic obstructive pulmonary disease	0.00017	0.0017	CcSEcCtD
Amiodarone—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000169	0.0017	CcSEcCtD
Amiodarone—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.0017	CcSEcCtD
Amiodarone—SIGMAR1—bronchus—chronic obstructive pulmonary disease	0.000169	0.0416	CbGeAlD
Amiodarone—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00169	CcSEcCtD
Amiodarone—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00169	CcSEcCtD
Amiodarone—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.00169	CcSEcCtD
Amiodarone—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000168	0.00169	CcSEcCtD
Amiodarone—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000168	0.00169	CcSEcCtD
Amiodarone—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000168	0.00169	CcSEcCtD
Amiodarone—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00168	CcSEcCtD
Amiodarone—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00168	CcSEcCtD
Amiodarone—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000165	0.00166	CcSEcCtD
Amiodarone—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000165	0.00166	CcSEcCtD
Amiodarone—SIGMAR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000165	0.0407	CbGeAlD
Amiodarone—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00166	CcSEcCtD
Amiodarone—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000164	0.00165	CcSEcCtD
Amiodarone—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.00164	CcSEcCtD
Amiodarone—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00163	CcSEcCtD
Amiodarone—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00163	CcSEcCtD
Amiodarone—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00163	CcSEcCtD
Amiodarone—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00163	CcSEcCtD
Amiodarone—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00162	CcSEcCtD
Amiodarone—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00162	CcSEcCtD
Amiodarone—Infection—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00162	CcSEcCtD
Amiodarone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000159	0.0016	CcSEcCtD
Amiodarone—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000159	0.0016	CcSEcCtD
Amiodarone—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.0016	CcSEcCtD
Amiodarone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000159	0.00159	CcSEcCtD
Amiodarone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00159	CcSEcCtD
Amiodarone—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00159	CcSEcCtD
Amiodarone—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00159	CcSEcCtD
Amiodarone—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00159	CcSEcCtD
Amiodarone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00158	CcSEcCtD
Amiodarone—Infection—Montelukast—chronic obstructive pulmonary disease	0.000158	0.00158	CcSEcCtD
Amiodarone—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.00158	CcSEcCtD
Amiodarone—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000157	0.00158	CcSEcCtD
Amiodarone—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.00158	CcSEcCtD
Amiodarone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000157	0.00158	CcSEcCtD
Amiodarone—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.00157	CcSEcCtD
Amiodarone—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000155	0.00156	CcSEcCtD
Amiodarone—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000154	0.00155	CcSEcCtD
Amiodarone—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00154	CcSEcCtD
Amiodarone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00154	CcSEcCtD
Amiodarone—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00153	CcSEcCtD
Amiodarone—SIGMAR1—trachea—chronic obstructive pulmonary disease	0.000152	0.0373	CbGeAlD
Amiodarone—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000151	0.00152	CcSEcCtD
Amiodarone—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.00152	CcSEcCtD
Amiodarone—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.00152	CcSEcCtD
Amiodarone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000151	0.00151	CcSEcCtD
Amiodarone—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.00151	CcSEcCtD
Amiodarone—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00015	0.00151	CcSEcCtD
Amiodarone—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.0015	CcSEcCtD
Amiodarone—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.00149	CcSEcCtD
Amiodarone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000148	0.00149	CcSEcCtD
Amiodarone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.00149	CcSEcCtD
Amiodarone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.00147	CcSEcCtD
Amiodarone—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000146	0.00147	CcSEcCtD
Amiodarone—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00147	CcSEcCtD
Amiodarone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000146	0.00146	CcSEcCtD
Amiodarone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.00145	CcSEcCtD
Amiodarone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000144	0.00145	CcSEcCtD
Amiodarone—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000143	0.00144	CcSEcCtD
Amiodarone—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00144	CcSEcCtD
Amiodarone—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.00144	CcSEcCtD
Amiodarone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00143	CcSEcCtD
Amiodarone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00143	CcSEcCtD
Amiodarone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000142	0.00143	CcSEcCtD
Amiodarone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000142	0.00143	CcSEcCtD
Amiodarone—CYP2A6—lung—chronic obstructive pulmonary disease	0.000141	0.0348	CbGeAlD
Amiodarone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000141	0.00141	CcSEcCtD
Amiodarone—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.00141	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.00141	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00014	0.00141	CcSEcCtD
Amiodarone—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.00014	0.0344	CbGeAlD
Amiodarone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00014	0.0014	CcSEcCtD
Amiodarone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.0014	CcSEcCtD
Amiodarone—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00014	0.0014	CcSEcCtD
Amiodarone—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000138	0.00139	CcSEcCtD
Amiodarone—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000138	0.00139	CcSEcCtD
Amiodarone—Pain—Formoterol—chronic obstructive pulmonary disease	0.000138	0.00139	CcSEcCtD
Amiodarone—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000138	0.00139	CcSEcCtD
Amiodarone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.00139	CcSEcCtD
Amiodarone—CYP1A1—respiratory system—chronic obstructive pulmonary disease	0.000138	0.034	CbGeAlD
Amiodarone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.00138	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000137	0.00138	CcSEcCtD
Amiodarone—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000137	0.00137	CcSEcCtD
Amiodarone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.00137	CcSEcCtD
Amiodarone—Pain—Montelukast—chronic obstructive pulmonary disease	0.000136	0.00136	CcSEcCtD
Amiodarone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000135	0.00136	CcSEcCtD
Amiodarone—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000135	0.0332	CbGeAlD
Amiodarone—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.00136	CcSEcCtD
Amiodarone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.00135	CcSEcCtD
Amiodarone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000134	0.00135	CcSEcCtD
Amiodarone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000134	0.00135	CcSEcCtD
Amiodarone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.00134	CcSEcCtD
Amiodarone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000133	0.00134	CcSEcCtD
Amiodarone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000133	0.00134	CcSEcCtD
Amiodarone—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.00134	CcSEcCtD
Amiodarone—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00134	CcSEcCtD
Amiodarone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000133	0.00133	CcSEcCtD
Amiodarone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000132	0.00133	CcSEcCtD
Amiodarone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000132	0.00133	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.00133	CcSEcCtD
Amiodarone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.00133	CcSEcCtD
Amiodarone—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.00131	CcSEcCtD
Amiodarone—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.00131	CcSEcCtD
Amiodarone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00013	0.0013	CcSEcCtD
Amiodarone—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000129	0.00129	CcSEcCtD
Amiodarone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.00129	CcSEcCtD
Amiodarone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.00129	CcSEcCtD
Amiodarone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000128	0.00129	CcSEcCtD
Amiodarone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000128	0.00129	CcSEcCtD
Amiodarone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.00129	CcSEcCtD
Amiodarone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000128	0.00128	CcSEcCtD
Amiodarone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000126	0.00127	CcSEcCtD
Amiodarone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000126	0.00127	CcSEcCtD
Amiodarone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000126	0.00127	CcSEcCtD
Amiodarone—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00127	CcSEcCtD
Amiodarone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.00127	CcSEcCtD
Amiodarone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000126	0.00126	CcSEcCtD
Amiodarone—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.00126	CcSEcCtD
Amiodarone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000125	0.00126	CcSEcCtD
Amiodarone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000125	0.00126	CcSEcCtD
Amiodarone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.00126	CcSEcCtD
Amiodarone—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000123	0.00124	CcSEcCtD
Amiodarone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00122	CcSEcCtD
Amiodarone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00122	CcSEcCtD
Amiodarone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00122	CcSEcCtD
Amiodarone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.0012	CcSEcCtD
Amiodarone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000119	0.0012	CcSEcCtD
Amiodarone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000119	0.0012	CcSEcCtD
Amiodarone—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.0012	CcSEcCtD
Amiodarone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000117	0.00117	CcSEcCtD
Amiodarone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.00117	CcSEcCtD
Amiodarone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000116	0.00117	CcSEcCtD
Amiodarone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.00115	CcSEcCtD
Amiodarone—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000115	0.00115	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00115	CcSEcCtD
Amiodarone—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00115	CcSEcCtD
Amiodarone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000114	0.00114	CcSEcCtD
Amiodarone—ADRB1—lung—chronic obstructive pulmonary disease	0.000114	0.028	CbGeAlD
Amiodarone—CYP1A1—bronchus—chronic obstructive pulmonary disease	0.000113	0.0279	CbGeAlD
Amiodarone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.00113	CcSEcCtD
Amiodarone—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000112	0.00113	CcSEcCtD
Amiodarone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000111	0.00111	CcSEcCtD
Amiodarone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.00111	CcSEcCtD
Amiodarone—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.00111	CcSEcCtD
Amiodarone—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00011	0.0011	CcSEcCtD
Amiodarone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.0011	CcSEcCtD
Amiodarone—SIGMAR1—lung—chronic obstructive pulmonary disease	0.000109	0.0268	CbGeAlD
Amiodarone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000109	0.00109	CcSEcCtD
Amiodarone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.00109	CcSEcCtD
Amiodarone—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.00108	CcSEcCtD
Amiodarone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000107	0.00108	CcSEcCtD
Amiodarone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.00108	CcSEcCtD
Amiodarone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000105	0.00105	CcSEcCtD
Amiodarone—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000105	0.00105	CcSEcCtD
Amiodarone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.00105	CcSEcCtD
Amiodarone—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000103	0.00104	CcSEcCtD
Amiodarone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.00104	CcSEcCtD
Amiodarone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000103	0.00104	CcSEcCtD
Amiodarone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.00103	CcSEcCtD
Amiodarone—Rash—Formoterol—chronic obstructive pulmonary disease	0.000102	0.00103	CcSEcCtD
Amiodarone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.00103	CcSEcCtD
Amiodarone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000102	0.00103	CcSEcCtD
Amiodarone—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000102	0.00103	CcSEcCtD
Amiodarone—CYP1A1—trachea—chronic obstructive pulmonary disease	0.000102	0.0251	CbGeAlD
Amiodarone—Headache—Formoterol—chronic obstructive pulmonary disease	0.000101	0.00102	CcSEcCtD
Amiodarone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.00102	CcSEcCtD
Amiodarone—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00102	CcSEcCtD
Amiodarone—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.00102	CcSEcCtD
Amiodarone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.00102	CcSEcCtD
Amiodarone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000101	0.00101	CcSEcCtD
Amiodarone—Rash—Montelukast—chronic obstructive pulmonary disease	0.0001	0.00101	CcSEcCtD
Amiodarone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	9.99e-05	0.001	CcSEcCtD
Amiodarone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	9.97e-05	0.001	CcSEcCtD
Amiodarone—Headache—Montelukast—chronic obstructive pulmonary disease	9.94e-05	0.000999	CcSEcCtD
Amiodarone—Angioedema—Prednisolone—chronic obstructive pulmonary disease	9.82e-05	0.000987	CcSEcCtD
Amiodarone—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	9.79e-05	0.000985	CcSEcCtD
Amiodarone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	9.72e-05	0.000977	CcSEcCtD
Amiodarone—Malaise—Prednisolone—chronic obstructive pulmonary disease	9.69e-05	0.000974	CcSEcCtD
Amiodarone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	9.65e-05	0.000971	CcSEcCtD
Amiodarone—Rash—Salbutamol—chronic obstructive pulmonary disease	9.64e-05	0.000969	CcSEcCtD
Amiodarone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	9.63e-05	0.000968	CcSEcCtD
Amiodarone—Nausea—Formoterol—chronic obstructive pulmonary disease	9.62e-05	0.000967	CcSEcCtD
Amiodarone—Nausea—Arformoterol—chronic obstructive pulmonary disease	9.62e-05	0.000967	CcSEcCtD
Amiodarone—Headache—Salbutamol—chronic obstructive pulmonary disease	9.58e-05	0.000963	CcSEcCtD
Amiodarone—Nausea—Montelukast—chronic obstructive pulmonary disease	9.42e-05	0.000947	CcSEcCtD
Amiodarone—Bradycardia—Prednisone—chronic obstructive pulmonary disease	9.13e-05	0.000918	CcSEcCtD
Amiodarone—Nausea—Salbutamol—chronic obstructive pulmonary disease	9.08e-05	0.000913	CcSEcCtD
Amiodarone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	9.04e-05	0.000909	CcSEcCtD
Amiodarone—Hallucination—Prednisone—chronic obstructive pulmonary disease	8.92e-05	0.000897	CcSEcCtD
Amiodarone—Oedema—Prednisolone—chronic obstructive pulmonary disease	8.77e-05	0.000882	CcSEcCtD
Amiodarone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	8.77e-05	0.000882	CcSEcCtD
Amiodarone—Shock—Prednisolone—chronic obstructive pulmonary disease	8.63e-05	0.000867	CcSEcCtD
Amiodarone—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	8.56e-05	0.00086	CcSEcCtD
Amiodarone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	8.48e-05	0.000852	CcSEcCtD
Amiodarone—Flushing—Prednisone—chronic obstructive pulmonary disease	8.32e-05	0.000837	CcSEcCtD
Amiodarone—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	8.01e-05	0.000806	CcSEcCtD
Amiodarone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	7.93e-05	0.000797	CcSEcCtD
Amiodarone—Alopecia—Prednisone—chronic obstructive pulmonary disease	7.93e-05	0.000797	CcSEcCtD
Amiodarone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	7.87e-05	0.000792	CcSEcCtD
Amiodarone—Erythema—Prednisone—chronic obstructive pulmonary disease	7.81e-05	0.000785	CcSEcCtD
Amiodarone—Pain—Prednisolone—chronic obstructive pulmonary disease	7.5e-05	0.000754	CcSEcCtD
Amiodarone—CYP1A2—lung—chronic obstructive pulmonary disease	7.42e-05	0.0183	CbGeAlD
Amiodarone—Vision blurred—Prednisone—chronic obstructive pulmonary disease	7.36e-05	0.00074	CcSEcCtD
Amiodarone—CYP1A1—lung—chronic obstructive pulmonary disease	7.32e-05	0.018	CbGeAlD
Amiodarone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	7.24e-05	0.000728	CcSEcCtD
Amiodarone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	7.23e-05	0.000727	CcSEcCtD
Amiodarone—Agitation—Prednisone—chronic obstructive pulmonary disease	7.17e-05	0.000721	CcSEcCtD
Amiodarone—ABCB1—respiratory system—chronic obstructive pulmonary disease	7.16e-05	0.0176	CbGeAlD
Amiodarone—CYP3A5—lung—chronic obstructive pulmonary disease	7.16e-05	0.0176	CbGeAlD
Amiodarone—Angioedema—Prednisone—chronic obstructive pulmonary disease	7.13e-05	0.000717	CcSEcCtD
Amiodarone—Malaise—Prednisone—chronic obstructive pulmonary disease	7.04e-05	0.000708	CcSEcCtD
Amiodarone—Vertigo—Prednisone—chronic obstructive pulmonary disease	7.01e-05	0.000705	CcSEcCtD
Amiodarone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	6.97e-05	0.0007	CcSEcCtD
Amiodarone—Anxiety—Prednisone—chronic obstructive pulmonary disease	6.62e-05	0.000666	CcSEcCtD
Amiodarone—Discomfort—Prednisone—chronic obstructive pulmonary disease	6.57e-05	0.00066	CcSEcCtD
Amiodarone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.46e-05	0.00065	CcSEcCtD
Amiodarone—Oedema—Prednisone—chronic obstructive pulmonary disease	6.37e-05	0.000641	CcSEcCtD
Amiodarone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	6.37e-05	0.000641	CcSEcCtD
Amiodarone—Infection—Prednisone—chronic obstructive pulmonary disease	6.33e-05	0.000636	CcSEcCtD
Amiodarone—Shock—Prednisone—chronic obstructive pulmonary disease	6.27e-05	0.00063	CcSEcCtD
Amiodarone—Tachycardia—Prednisone—chronic obstructive pulmonary disease	6.22e-05	0.000625	CcSEcCtD
Amiodarone—Skin disorder—Prednisone—chronic obstructive pulmonary disease	6.19e-05	0.000622	CcSEcCtD
Amiodarone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	6.16e-05	0.000619	CcSEcCtD
Amiodarone—Anorexia—Prednisone—chronic obstructive pulmonary disease	6.07e-05	0.000611	CcSEcCtD
Amiodarone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.8e-05	0.000583	CcSEcCtD
Amiodarone—Insomnia—Prednisone—chronic obstructive pulmonary disease	5.76e-05	0.000579	CcSEcCtD
Amiodarone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	5.72e-05	0.000575	CcSEcCtD
Amiodarone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.61e-05	0.000564	CcSEcCtD
Amiodarone—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	5.54e-05	0.000557	CcSEcCtD
Amiodarone—Rash—Prednisolone—chronic obstructive pulmonary disease	5.53e-05	0.000556	CcSEcCtD
Amiodarone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.52e-05	0.000555	CcSEcCtD
Amiodarone—Fatigue—Prednisone—chronic obstructive pulmonary disease	5.49e-05	0.000552	CcSEcCtD
Amiodarone—Headache—Prednisolone—chronic obstructive pulmonary disease	5.49e-05	0.000552	CcSEcCtD
Amiodarone—Constipation—Prednisone—chronic obstructive pulmonary disease	5.45e-05	0.000548	CcSEcCtD
Amiodarone—ABCB1—trachea—chronic obstructive pulmonary disease	5.29e-05	0.013	CbGeAlD
Amiodarone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.25e-05	0.000528	CcSEcCtD
Amiodarone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.21e-05	0.000524	CcSEcCtD
Amiodarone—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.21e-05	0.000524	CcSEcCtD
Amiodarone—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.06e-05	0.000509	CcSEcCtD
Amiodarone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.04e-05	0.000506	CcSEcCtD
Amiodarone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.04e-05	0.000506	CcSEcCtD
Amiodarone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.69e-05	0.000472	CcSEcCtD
Amiodarone—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.57e-05	0.00046	CcSEcCtD
Amiodarone—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.51e-05	0.000453	CcSEcCtD
Amiodarone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.36e-05	0.000438	CcSEcCtD
Amiodarone—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.21e-05	0.000424	CcSEcCtD
Amiodarone—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.05e-05	0.000407	CcSEcCtD
Amiodarone—Rash—Prednisone—chronic obstructive pulmonary disease	4.02e-05	0.000404	CcSEcCtD
Amiodarone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.01e-05	0.000404	CcSEcCtD
Amiodarone—Headache—Prednisone—chronic obstructive pulmonary disease	3.99e-05	0.000401	CcSEcCtD
Amiodarone—ABCB1—lung—chronic obstructive pulmonary disease	3.8e-05	0.00937	CbGeAlD
Amiodarone—Nausea—Prednisone—chronic obstructive pulmonary disease	3.78e-05	0.000381	CcSEcCtD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	2.57e-05	0.000471	CbGpPWpGaD
Amiodarone—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.57e-05	0.000471	CbGpPWpGaD
Amiodarone—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.55e-05	0.000469	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.55e-05	0.000467	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.54e-05	0.000467	CbGpPWpGaD
Amiodarone—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.53e-05	0.000465	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.52e-05	0.000463	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	2.52e-05	0.000462	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	2.52e-05	0.000462	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—IL6—chronic obstructive pulmonary disease	2.52e-05	0.000462	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	2.48e-05	0.000454	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.47e-05	0.000453	CbGpPWpGaD
Amiodarone—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.46e-05	0.000451	CbGpPWpGaD
Amiodarone—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.43e-05	0.000447	CbGpPWpGaD
Amiodarone—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.42e-05	0.000444	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.42e-05	0.000444	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	2.41e-05	0.000441	CbGpPWpGaD
Amiodarone—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.4e-05	0.00044	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	2.4e-05	0.00044	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	2.4e-05	0.00044	CbGpPWpGaD
Amiodarone—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.39e-05	0.000438	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.38e-05	0.000437	CbGpPWpGaD
Amiodarone—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.35e-05	0.000432	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.34e-05	0.000429	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.34e-05	0.000429	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.33e-05	0.000428	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.31e-05	0.000424	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.3e-05	0.000422	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	2.27e-05	0.000417	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	2.27e-05	0.000416	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.23e-05	0.00041	CbGpPWpGaD
Amiodarone—EBP—Metabolism—ALB—chronic obstructive pulmonary disease	2.23e-05	0.000409	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.22e-05	0.000408	CbGpPWpGaD
Amiodarone—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.21e-05	0.000405	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.21e-05	0.000405	CbGpPWpGaD
Amiodarone—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.19e-05	0.000403	CbGpPWpGaD
Amiodarone—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.18e-05	0.0004	CbGpPWpGaD
Amiodarone—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.16e-05	0.000397	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	2.15e-05	0.000394	CbGpPWpGaD
Amiodarone—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	2.15e-05	0.000394	CbGpPWpGaD
Amiodarone—EBP—Metabolism—NOS3—chronic obstructive pulmonary disease	2.13e-05	0.000392	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.11e-05	0.000387	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	2.1e-05	0.000385	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	2.09e-05	0.000383	CbGpPWpGaD
Amiodarone—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.08e-05	0.000382	CbGpPWpGaD
Amiodarone—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.05e-05	0.000376	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	1.98e-05	0.000362	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	1.96e-05	0.000359	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	1.95e-05	0.000358	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.87e-05	0.000343	CbGpPWpGaD
Amiodarone—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.84e-05	0.000338	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.84e-05	0.000338	CbGpPWpGaD
Amiodarone—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.82e-05	0.000333	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.8e-05	0.000329	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.79e-05	0.000329	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	1.79e-05	0.000328	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.74e-05	0.000319	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.72e-05	0.000316	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.72e-05	0.000315	CbGpPWpGaD
Amiodarone—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.69e-05	0.000311	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.69e-05	0.000311	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	1.69e-05	0.00031	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.67e-05	0.000307	CbGpPWpGaD
Amiodarone—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.67e-05	0.000306	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.66e-05	0.000305	CbGpPWpGaD
Amiodarone—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.61e-05	0.000295	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.6e-05	0.000293	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.59e-05	0.000292	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—ALB—chronic obstructive pulmonary disease	1.59e-05	0.000292	CbGpPWpGaD
Amiodarone—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.58e-05	0.00029	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.58e-05	0.00029	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.57e-05	0.000288	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	1.55e-05	0.000284	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.53e-05	0.000281	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.52e-05	0.000279	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.45e-05	0.000266	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.44e-05	0.000264	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.43e-05	0.000262	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.42e-05	0.000261	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.41e-05	0.000259	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.4e-05	0.000256	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.39e-05	0.000255	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.38e-05	0.000254	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.36e-05	0.00025	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.36e-05	0.00025	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.35e-05	0.000248	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.35e-05	0.000248	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	1.34e-05	0.000245	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.31e-05	0.00024	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.3e-05	0.000238	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.29e-05	0.000238	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.29e-05	0.000237	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.29e-05	0.000236	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.29e-05	0.000236	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.27e-05	0.000234	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.26e-05	0.000232	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.26e-05	0.00023	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.25e-05	0.000229	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.24e-05	0.000228	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.23e-05	0.000225	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.22e-05	0.000224	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.19e-05	0.000219	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.18e-05	0.000217	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.17e-05	0.000215	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.15e-05	0.000211	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.13e-05	0.000208	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.12e-05	0.000206	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.12e-05	0.000206	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.12e-05	0.000205	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.11e-05	0.000203	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.08e-05	0.000198	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.08e-05	0.000198	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.03e-05	0.000189	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.03e-05	0.000189	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.03e-05	0.000188	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.01e-05	0.000185	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1e-05	0.000184	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.98e-06	0.000183	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.78e-06	0.000179	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	9.67e-06	0.000177	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	9.62e-06	0.000177	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.38e-06	0.000172	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	9.35e-06	0.000171	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.27e-06	0.00017	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.25e-06	0.00017	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.24e-06	0.00017	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	9.13e-06	0.000168	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	8.82e-06	0.000162	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.62e-06	0.000158	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.6e-06	0.000158	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.56e-06	0.000157	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.56e-06	0.000157	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.52e-06	0.000156	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	8.48e-06	0.000156	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.48e-06	0.000156	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.47e-06	0.000155	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	8.37e-06	0.000154	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	8.33e-06	0.000153	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	8.32e-06	0.000153	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.17e-06	0.00015	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.13e-06	0.000149	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.99e-06	0.000147	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.9e-06	0.000145	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.81e-06	0.000143	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.74e-06	0.000142	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.71e-06	0.000141	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.68e-06	0.000141	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.65e-06	0.00014	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	7.64e-06	0.00014	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.56e-06	0.000139	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.49e-06	0.000137	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	7.47e-06	0.000137	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.38e-06	0.000135	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.29e-06	0.000134	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.04e-06	0.000129	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7e-06	0.000128	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.97e-06	0.000128	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.95e-06	0.000128	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.95e-06	0.000128	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.89e-06	0.000126	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	6.87e-06	0.000126	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	6.82e-06	0.000125	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	6.81e-06	0.000125	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.78e-06	0.000124	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.69e-06	0.000123	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.69e-06	0.000123	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.66e-06	0.000122	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.47e-06	0.000119	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.4e-06	0.000118	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.35e-06	0.000117	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.32e-06	0.000116	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.28e-06	0.000115	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	6.27e-06	0.000115	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.23e-06	0.000114	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.22e-06	0.000114	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	6.22e-06	0.000114	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.13e-06	0.000113	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.91e-06	0.000108	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.89e-06	0.000108	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.88e-06	0.000108	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.87e-06	0.000108	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	5.82e-06	0.000107	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.79e-06	0.000106	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.78e-06	0.000106	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.73e-06	0.000105	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	5.55e-06	0.000102	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.43e-06	9.96e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.4e-06	9.9e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.31e-06	9.75e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	5.31e-06	9.75e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.24e-06	9.62e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.17e-06	9.48e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.11e-06	9.38e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.11e-06	9.38e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.11e-06	9.38e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	5.09e-06	9.34e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.04e-06	9.26e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.88e-06	8.96e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.87e-06	8.93e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.82e-06	8.84e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.82e-06	8.84e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.78e-06	8.77e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.75e-06	8.72e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.71e-06	8.65e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.7e-06	8.62e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.66e-06	8.55e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.57e-06	8.38e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.55e-06	8.34e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	4.49e-06	8.25e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.46e-06	8.18e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.43e-06	8.13e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.39e-06	8.06e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.2e-06	7.7e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.16e-06	7.64e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.13e-06	7.58e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.1e-06	7.52e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.08e-06	7.49e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.03e-06	7.39e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	4.01e-06	7.36e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.93e-06	7.21e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	3.84e-06	7.04e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	3.79e-06	6.96e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.78e-06	6.93e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.75e-06	6.88e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.74e-06	6.86e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.63e-06	6.66e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.56e-06	6.53e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	3.48e-06	6.38e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.36e-06	6.16e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	3.33e-06	6.1e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.15e-06	5.78e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.11e-06	5.7e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	3.1e-06	5.69e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.08e-06	5.65e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	3.03e-06	5.56e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.02e-06	5.54e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	2.97e-06	5.45e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.9e-06	5.32e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.9e-06	5.31e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2.85e-06	5.24e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	2.83e-06	5.19e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.75e-06	5.04e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.73e-06	5.01e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.71e-06	4.97e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.54e-06	4.65e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.42e-06	4.44e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.32e-06	4.26e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.31e-06	4.24e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.87e-06	3.42e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.79e-06	3.28e-05	CbGpPWpGaD
